Stukov Yuriy, Rackauskas Mindaugas, Maybauer Marc O
Division of Thoracic Surgery, Department of Surgery, University of Florida, FL, USA.
Division of Critical Care Medicine, Department of Anesthesiology, University of Florida, FL, USA.
Ann Card Anaesth. 2025 Apr 1;28(2):190-192. doi: 10.4103/aca.aca_194_24. Epub 2025 Mar 20.
Venovenous extracorporeal membrane oxygenation is the most commonly used mode of support in pre-lung transplant recipients. In patients who experience right ventricular dysfunction, venopulmonary ECMO is an excellent option to preserve RV function. We retrospectively reviewed patients who were supported with venopulmonary ECMO. Descriptive analysis, patient characteristics, ECMO outcomes, and survival were assessed. The primary outcome was mortality. Mean age was 45.5 ± 15.63, mean ECMO hours 1391.75 ± 1239.01. 4 patients had right ventricular dysfunction. All patients received bilateral orthotopic lung transplant. One-year survival was 100% for all patients. Venopulmonary extracorporeal membrane oxygenation can be safely used to bridge patients with end-stage lung disease to lung transplantation.
静脉-静脉体外膜肺氧合是肺移植术前受者最常用的支持模式。在出现右心室功能障碍的患者中，静脉-肺体外膜肺氧合是保留右心室功能的极佳选择。我们回顾性分析了接受静脉-肺体外膜肺氧合支持的患者。评估了描述性分析、患者特征、体外膜肺氧合结果和生存率。主要结局指标是死亡率。平均年龄为45.5±15.63岁，平均体外膜肺氧合时间为1391.75±1239.01小时。4例患者存在右心室功能障碍。所有患者均接受了双侧原位肺移植。所有患者的1年生存率为100%。静脉-肺体外膜肺氧合可安全用于将终末期肺病患者过渡到肺移植。
